Olink Proteomics

Ready to bring your proteomics discoveries to the clinic? Join our upcoming webinar, where our experts will guide you through the journey of bringing proteomics from discovery to the clinic. Learn how broad biomarker discovery can be scaled seamlessly to clinical applications, with real-world examples in Alzheimer's Disease and Multiple Sclerosis. We’re offering two sessions to fit your time zone, and our experts will be on hand to answer your questions live. Don’t miss out and register now! Date: November 19th Session 1: 9 AM GMT / 10 AM CET Session 2: 11 AM EST / 8 AM PST https://bit.ly/3AnXsHc

We're #hiring a new Business Development Manager MidPlex - South West UK in London, England. Apply today or share this post with your network.

Olink Proteomics, our team and partners are revving to go for ASHG 2024 that will take place in beautiful Denver Colorado in the Colorado Convention Center. Please join us at our CoLab event in Theatre 3 on Wed Nov 6 2:30-3pm MT where M. Austin Argentieri and our own Tony (Heng) Qian will join me to talk about the magic of combining multimomic data in population cohorts. At 3pm MT Evan Mills will lead our industry session that will include a panel discussion on Public Private Partnerships in Room 107 in the Colorado Convention Center. We will hear from Carlos Cruchaga, Joanna Howson, A. Gaye, Melissa Miller, Ryan Dhindsa, and last but certainly not least, Chris Whelan. Find our team at Booth #312 in the Exhibit Hall. We look forward to seeing many of you there!

This week we are at #SITC2024, the largest cancer immunotherapy conference, and naturally, we are thinking about what emerging technologies will have the biggest impact on immunotherapy research. What do you think? Of the technologies listed below which do you predict will have the biggest impact on immunotherapy research in the next 5 years? Have a different prediction? Leave your predictions in the comments.

Dr. Chris Whelan, Director of Neuroscience Data Science at Johnson & Johnson, recently shared a vision for population proteomics during his keynote presentation at the Olink Proteomics World event. In his talk, he explains how population-based, clinical, and translational proteomics will advance precision medicine. You can still watch this presentation on-demand, along with all other event sessions. In this talk, he dives deep into how population-based, clinical & translational proteomics will drive precision medicine. You can still watch this presentation on-demand and all the other presentations from the event. Learn more: https://hubs.ly/Q02WtLwn0

Before traveling to ASHG 2024, Evan Mills has a message for everyone who will be headed to the conference as well. "I have the distinct honor of hosting a panel discussion around public-private partnerships and how they can help advance precision medicine initiatives...The panel is comprised of leading scientists in their respective fields within industry, academia, and government. It's going to be really good opportunity to learn about how to be most impactful and effective in these public-private partnerships. We are going to get specific examples of what is going really well." The session is on Wednesday, November 6 at 3:00 PM MDT Safe travels to everyone going to ASHG 2024. We are looking forward to seeing you in Denver. Let us know in the comments if you will be there!

We will be exhibiting at ASHG 2024, Nov. 5-9 in Denver! Join us at booth #771 and come to our education luncheon co-hosted with Olink Proteomics on Nov. 7 at 12pm: Title: Proteomic and Genomic Biomarker Profiling Strategies: Analytical Approaches and Data Insights Across Multiple Sample Matrices    Presented by: Donald Skifter, PhD, MBA, Danielle Gutierrez, Tony (Heng) Qian, and Cynthia 辛西娅 Lawley 劳利 Click here to schedule a private meeting with our experts: https://lnkd.in/er5undXJ #ASHG24 #Genomics #Proteomics #Olink #OlinkCertifiedServiceProviders

Population-scale proteogenomic studies linking gene variants that regulate protein expression (“pQTLs”) to clinical phenotypes are rapidly enhancing our understanding of disease biology and accelerating drug development but have been limited by a focus on individuals of White European ancestry. Today’s #weeklyread describes an important study from researchers at Harvard Medical School, who used the Olink® Explore platform to measure ~3,000 proteins in 1,054 Black American adults to gain new biological insights that expand on previous studies by addressing broader genetic diversity. Key highlights • 1002 pQTLs were Identified for 925 proteins, 86% of which could be replicated in a validation cohort. • There was significant overlap with data from the mostly White European ancestry UK Biobank Pharma Proteomics Project, but 43% of the proteins measured had pQTL sets that were distinct from those reported in UKB. • 55 proteins showed statistically significant signals of association with gene variants enriched in African ancestry, many linked to diseases that lack precise biomarkers These findings have been made available as an online resource for the wider scientific community. The authors concluded, “Our GWAS findings underscore the importance of genetic diversity, especially for variants nearly absent in the European population, to uncover, clinically relevant findings”. Read the article: https://hubs.la/Q02W6dB-0 #olink #proteomics #precisionmedicine

We're #hiring a new Field Application Scientist - DACH/France in Paris, Île-de-France. Apply today or share this post with your network.

When developing immunoassays, how can we ensure that high sensitivity translates into capturing true biological signal? Join our upcoming webinar for a comprehensive overview of the challenges and opportunities in the protein biomarker development pipeline, by exploring: - Key assay development steps ensuring that true biological signal is measured with high specificity and sensitivity. - The need for rigorous and transparent assay validation. - How the Proximity Extension Assay technology is addressing these challenges to accelerate the journey from biomarker discovery to clinical utility. Reserve your spot now https://hubs.la/Q02VCvT_0 #Olink